Where is the live CopyMark page for USPTO serial 99863311?

The live record is at https://getcopymark.com/trademark/99863311. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns ICLUCIA THERAPEUTICS?

According to the public USPTO record for serial number 99863311, the listed owner(s) include: ICLUCIA Therapeutics, Inc..

What is USPTO serial number 99863311?

Serial number 99863311 is the USPTO application identifier for the mark ICLUCIA THERAPEUTICS. It is used to track examination, publication, and registration of this trademark.

What is the current status of ICLUCIA THERAPEUTICS?

ICLUCIA THERAPEUTICS (99863311) currently shows USPTO status code 681 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover ICLUCIA THERAPEUTICS?

The public record lists International Classes: 005, 042, 045. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: ICLUCIA THERAPEUTICS Serial# 99863311 | status 681; last event NONP | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ICLUCIA THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

ICLUCIA Therapeutics, Inc.
Boston, MA, US
Other trademarks owned by ICLUCIA Therapeutics, Inc.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole Kinsley, Esq.

Nicole Kinsley, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport WestBoston, MA 02210-2600

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for gene therapy for the treatment of cancer and rare diseases	ACTIVE	—
042	Research and development in the field of pharmaceuticals; Consulting services in the field of pharmaceutical research and development; Providing scientific research information in the field of genetics; Providing medical research information in the field of genetics; Providing scientific research information in the field of pharmaceuticals; Providing medical research information in the field of pharmaceuticals	ACTIVE	—
045	Patent licensing; Licensing of intellectual property in the field of genetics and pharmaceuticals	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 4, 2026	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Oct 9, 2026	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 9, 2026	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	—
Oct 9, 2026	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Oct 9, 2026	GNEA	EXAMINERS AMENDMENT E-MAILED	—
Oct 9, 2026	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Oct 8, 2026	DOCK	ASSIGNED TO EXAMINER	—
Oct 7, 2026	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jun 3, 2026	MAFR	APPLICATION FILING RECEIPT MAILED	—
Jun 3, 2026	NWAP	NEW APPLICATION ENTERED	—

ICLUCIA THERAPEUTICS